Future prevalence of type 2 diabetes—A comparative analysis of chronic disease projection methods

Voeltz D, Tönnies T, Brinks R, Hoyer A (2022)
PLOS ONE 17(3): e0264739.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
OA 747.94 KB
Autor*in
Voeltz, DinaUniBi ; Tönnies, Thaddäus; Brinks, Ralph; Hoyer, AnnikaUniBi
Abstract / Bemerkung
**Background**
Accurate projections of the future number of people with chronic diseases are necessary for effective resource allocation and health care planning in response to changes in disease burden. **Aim**
To introduce and compare different projection methods to estimate the number of people with diagnosed type 2 diabetes (T2D) in Germany in 2040. **Methods**
We compare three methods to project the number of males with T2D in Germany in 2040. Method 1) simply combines the sex- and age-specific prevalence of T2D in 2010 with future population distributions projected by the German Federal Statistical Office (FSO). Methods 2) and 3) additionally account for the incidence of T2D and mortality rates using partial differential equations (PDEs). Method 2) models the prevalence of T2D employing a scalar PDE which incorporates incidence and mortality rates. Subsequently, the estimated prevalence is applied to the population projection of the FSO. Method 3) uses a two-dimensional system of PDEs and estimates future case numbers directly while future mortality of people with and without T2D is modelled independently from the projection of the FSO. **Results**
Method 1) projects 3.6 million male people with diagnosed T2D in Germany in 2040. Compared to 2.8 million males in 2010, this equals an increase by 29%. Methods 2) and 3) project 5.9 million (+104% compared to 2010) and 6.0 million (+116%) male T2D patients, respectively. **Conclusions**
The results of the three methods differ substantially. It appears that ignoring temporal trends in incidence and mortality may result in misleading projections of the future number of people with chronic diseases. Hence, it is essential to include these rates as is done by method 2) and 3).
Erscheinungsjahr
2022
Zeitschriftentitel
PLOS ONE
Band
17
Ausgabe
3
Art.-Nr.
e0264739
eISSN
1932-6203
Finanzierungs-Informationen
Open-Access-Publikationskosten wurden durch die Universität Bielefeld gefördert.
Page URI
https://pub.uni-bielefeld.de/record/2961681

Zitieren

Voeltz D, Tönnies T, Brinks R, Hoyer A. Future prevalence of type 2 diabetes—A comparative analysis of chronic disease projection methods. PLOS ONE. 2022;17(3): e0264739.
Voeltz, D., Tönnies, T., Brinks, R., & Hoyer, A. (2022). Future prevalence of type 2 diabetes—A comparative analysis of chronic disease projection methods. PLOS ONE, 17(3), e0264739. https://doi.org/10.1371/journal.pone.0264739
Voeltz, Dina, Tönnies, Thaddäus, Brinks, Ralph, and Hoyer, Annika. 2022. “Future prevalence of type 2 diabetes—A comparative analysis of chronic disease projection methods”. PLOS ONE 17 (3): e0264739.
Voeltz, D., Tönnies, T., Brinks, R., and Hoyer, A. (2022). Future prevalence of type 2 diabetes—A comparative analysis of chronic disease projection methods. PLOS ONE 17:e0264739.
Voeltz, D., et al., 2022. Future prevalence of type 2 diabetes—A comparative analysis of chronic disease projection methods. PLOS ONE, 17(3): e0264739.
D. Voeltz, et al., “Future prevalence of type 2 diabetes—A comparative analysis of chronic disease projection methods”, PLOS ONE, vol. 17, 2022, : e0264739.
Voeltz, D., Tönnies, T., Brinks, R., Hoyer, A.: Future prevalence of type 2 diabetes—A comparative analysis of chronic disease projection methods. PLOS ONE. 17, : e0264739 (2022).
Voeltz, Dina, Tönnies, Thaddäus, Brinks, Ralph, and Hoyer, Annika. “Future prevalence of type 2 diabetes—A comparative analysis of chronic disease projection methods”. PLOS ONE 17.3 (2022): e0264739.
Alle Dateien verfügbar unter der/den folgenden Lizenz(en):
Creative Commons Namensnennung 4.0 International Public License (CC-BY 4.0):
Volltext(e)
Access Level
OA Open Access
Zuletzt Hochgeladen
2022-10-13T06:46:15Z
MD5 Prüfsumme
7362d07f76b36abeb6655b75114edee3


Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Quellen

PMID: 35255104
PubMed | Europe PMC

Preprint: 10.1101/2021.11.25.21266868

Suchen in

Google Scholar